Video

Michel Berg, MD

Publish date: December 11, 2015

At the 69th Annual Meeting of the American Epilepsy Society, Dr. Berg discusses findings from the Equivalence Among Generic Antiepileptic Drugs (EQUIGEN) single-dose study.

 

References

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

What Is the Rate of SUDEP in Patients Treated With RNS?
MDedge Neurology
How Should Neurologists Counsel Families About Pediatric Epilepsy Surgery Outcomes?
MDedge Neurology
Lara Jehi, MD
MDedge Neurology
AES: Neurologists ignore low driving risk from epilepsy-drug withdrawal
MDedge Neurology
Are Generic and Branded Versions of Lamotrigine Bioequivalent?
MDedge Neurology
Some Patients With SUDEP Have Genetic Mutation That Causes Cardiac Sudden Death
MDedge Neurology
Continuous IV Therapy May Be Inappropriate for Some Children With Refractory Status Epilepticus
MDedge Neurology
AES: Hormonal contraceptives can boost seizures in epileptics
MDedge Neurology
AES: Cannabidiol shows promising epilepsy safety and efficacy
MDedge Neurology
AES: Many U.S. epilepsy patients receive suboptimal treatment
MDedge Neurology

Related Articles